drugset / Trial / NCT00417820

Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.

NCT00417820 ↗

Phase 1 Completed 35 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the local tolerability of a single topical administration of BCT194 in healthy volunteers and, potentially, to evaluate the safety, tolerability, and efficacy of a multiple topical administrations in patients with psoriasis.

Timeline

Start
2006-11
Primary completion
—
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BCT194 Unknown — Topical

Indications